全国文明单位、国家临床重点专科建设单位——福建省肿瘤医院位于福州市晋安区福马路420号，医院占地面积9.37万平方米，建筑面积18.71万平方米，医疗用房13.57万平方米，是福建省唯一的集预防、医疗、康复、科研、教学和培训于一体的三级甲等肿瘤医院。在历届省委、省政府和各级领导及社会各界的关心支持下，医院于1979年筹建，1984年收治病人，1986年11月12日正式挂牌开院，1997年被国家卫生部评为三级甲等肿瘤医院，1998年被国家卫生部批准为“卫生部临床药理实验基地”，2013年被国家卫生计生委确认为肿瘤科国家临床重点专科建设项目，放射治疗科、中西医结合科被列为省级重点专科建设项目。2001年成立省肿瘤研究所合署办公。2016年成为福建医科大学附属肿瘤医院，2017年被列入福建省高水平癌症医学中心建设单位，2018获首批全国消化肿瘤MDT培训示范中心、中国医师协会腹腔镜外科医师培训基地、全国难治性疼痛规范化诊疗示范基地等，近几年连续获复旦版全国最佳专科（肿瘤学）排行榜提名医院、华东区肿瘤学专科榜第五名等。福建省癌症中心、福建省肿瘤防治研究办公室、福建省抗癌协会、福建省医学会肿瘤学分会、福建省医学会放射肿瘤学分会、福建省肿瘤放射治疗质量控制中心、福建省肿瘤化学治疗质量控制中心、福建省核学会、福建医科大学肿瘤医院临床及专业教研室和中国抗癌协会鼻咽癌专业委员会均挂靠在福建省肿瘤医院。 

　　经过30多年的努力，医院在医疗技术、设备、服务、环境、人才培养、医疗管理和医院文化建设等方面都取得了跨越式发展。医院编制床位1600张，年收治肿瘤病人7万余人次，设有31个临床科室、27个病区、11个医技科室和14个肿瘤基础研究室（2个省级重点实验室）。现有职工2018人，卫生技术人员1654人，其中正高职称76人，副高职称159人，博士、硕士319人，教授、副教授43人，博士、硕士生导师40人，享受国务院特殊津贴专家6人。 

　　医院重视学科建设发展，提高管理水平，强化肿瘤综合治疗和技术创新，形成了以肿瘤外科治疗、肿瘤放射治疗、肿瘤内科治疗、中西医结合治疗、生物治疗、射频消融治疗、介入治疗和热疗等为特色的规范化肿瘤多学科综合治疗体系。近年来，医院完成科研课题160多项，其中，国家级项目19项，省（部）级项目73项，厅级项目56项。获省部级和省级相关行业科技成果奖90多项。发表医学论文2800多篇。主编出版《常见恶性肿瘤综合治疗指南与实施》、《福建省肿瘤登记报告》、《鼻咽癌》、《腹膜后肿瘤》、《头颈部肿瘤放射治疗》、《福建省胃癌高发现场病因研究》、《福建省恶性肿瘤地图集》、《常见恶性肿瘤病理组织学与免疫组织化学彩色图谱》等10多部专著。主办和承办了全国胃肠肿瘤微创外科高峰论坛暨胃肠肿瘤腹腔镜手术新进展学习班、全国肝癌学术大会、近距离放射治疗国际会议、全国鼻咽癌学术大会、全国肺癌学术大会、全国癌症康复与姑息治疗医学大会、全国肿瘤化疗学习班、全国肿瘤医院管理学术研讨会等70多次国际和全国肿瘤学术研讨会。 

　　在深化医药卫生体制改革的新形势下，医院立足自身实际，率先进行了人事制度岗位设置、主诊医师负责制诊疗运行模式、内部流程管理优化、绩效工资分配制度等一系列医院内部管理制度的改革，提升了医院管理水平和服务能力，有效改善了群众就医体验。

　　Profile of Fujian Provincial Cancer Hospital 

　　Overview 

　　Fujian Provincial Cancer Hospital (FPCH), one of the leading institutions in promoting socialist ethical progress, is situated at 420 Fuma Road, Jin’an District of Fuzhou. Neighbored to the downtown area in the west and Gushan Scenic Spot in the east, FPCH covers an area of 94,000 square meters, with a floor space of 195,000 square meters. FPCH is the only Triple-A cancer hospital in Fujian (3A Hospital, an award for top class hospitals according to the evaluation system of Ministry of Health, P. R. China) with an integrated system of medical treatment, scientific research, teaching, training, cancer prevention and rehabilitation. 

　　Development and Management 

　　The idea of establishing FPCH was first mooted in 1979. With the support from leaders, people of all walks of life as well as from different levels of provincial government, FPCH began to practice cancer curative activities from 1984 and was formally established on 12th November, 1986. In 1997, it was awarded as a “Triple-A Cancer Hospital” by Ministry of Health, PRC，and in 1998, it was authorized as “The Pilot Base of Clinical Pharmacology” by Ministry of Health, PRC. In 2001, Fujian Provincial Institute of Oncology was established in FPCH. 

　　Throughout 30 years’ of efforts, FPCH has achieved a leapfrog development in its medical technology, equipment, service standard, environment, talent cultivation, medical management and cultural construction. At present, FPCH has 31clinical departments, 27 wards, 11 medical technological departments and 14 oncology laboratories. The total number of our employees reaches 2,018. Among the 1,654health technicians, there are 76chief physicians, 159associate chief physicians, 319 MD (Doctor of Medicine) and MMedSc (Master of Medical Science)，43 professors and associate professors，30 doctor and master supervisors and 6 Government Special Allowance winners.

　　Based on its reality, FPCH has taken the lead in undertaking a series of reforms in some aspects as personnel system, responsibility system of attending doctor, internal process management optimization and merit pay system. 

　　Scope of Service 

　　By laying emphasis on development of disciplinary construction, improvement in management standards and innovation in comprehensive tumor treatment, FPCH has formed a sound and standard therapy system featuring by surgery, radiotherapy, chemotherapy, stem cell transplantation therapy, integrative medicine therapy, biotherapy, radio frequency ablation, intervention therapy and hyperthermia therapy. 

　　Cluster Relationship 

　　FPCH has some affiliated organizations like: 

　　Cancer Center of Fujian Province; 

　　Cancer Treatment, Prevention and Research Office of Fujian Province; 

　　Anti-Cancer Society of Fujian Province; 

　　Oncology Branch of Fujian Medical Association; 

　　Radiation Oncology Branch of Fujian Medical Association; 

　　Quality Control Center of Radiation Oncology, Fujian Province; 

　　Quality Control Center of Chemotherapy Oncology, Fujian Province; 

　　Teaching and Researching Base of Oncology, Fujian Medical University; 

　　National Committee of Nasopharyngeal Carcinoma, China Anti-Cancer Society. 

　　Scientific Research Achievements 

　　FPCH also pays great attention to scientific research. In recent years, the staff of FPCH have published more than 2600 papers in foreign and domestic journals and completed over 99 scientific research projects, including 84 provincial-level projects and 15 ministerial-level projects, and won more than 70 awards at both ministerial level and provincial level. More than 10 professional books have been published include: 

　　Comprehensive Treatment Guidelines of Common Malignancy; 

　　Guidelines for Fujian Cancer Registry Report; 

　　Nasopharyngeal Carcinoma; 

　　Retroperitoneal Neoplasm; 

　　Radiotherapy of Head and Neck Cancer; 

　　Study on Etiology of High Incidence Area of Gastric Cancer in Fujian Province; 

　　Atlantes of Malignancy in Fujian Province; 

　　The Histopathology and Immunohistochemistry of Common Malignancy; 

　　Common Neoplastic Diseases Care Manual. 

　　Academic Activities 

　　During these years, FPCH has successfully hosted more than 60 international and national conferences. Some of the academic workshops include: 

　　The Gastrointestinal Tumor Minimally Invasive Surgery Summit Forum and Training lesson of Gastrointestinal Tumor Laparoscopic Operation Progression; 

　　National Liver Cancer Conference; 

　　International Brachytherapy Conference; 

　　National Nasopharyngeal Cancer Conference; 

　　National Lung Cancer Conference; 

　　National Cancer Rehabilitation and Palliative Medicine Congress; 

　　National Tumor Chemotherapy Training Course; 

　　National Tumor Hospital Management Symposium.